CAMKK2 and neoplasm: The competitive ability of tumor chambers containing WT and Camkk2−/− BMDM was evaluated over a period of 72 h by wide-field imaging analysis of the entire microfluidic device, and the total number of OTI T cells within the microchannels and tumor chambers was quantified (Fig. 7d; Supplementary Fig. 9C).